pixabay.com

Nine CEOs of COVID-19 vaccines have assured  that safety of vaccinated individuals remains their top priority in development of the first COVID-19 vaccines.

Andrew Topen is the new Chairman of the European Association for Bioindustries EuropaBio.

The conditionally patented Bacteromic platform allows susceptibility testing by offering automated quantitative evaluation of all clinically relevant antibiotics in a single test. Additionally, a synergy panel identifies synergistic pairs of antibiotics. © Scope Fluidics SA Capital Group

The European Investment Bank has lend up to €10m to Polish microbial diagnostics specialist Scope Fluidics AS.

Antigen tests such as SD Biosensor‘s SARS-CoV-2 chromatographic assay do not need any instrumentation or additional reagents and thus can be performed at the point of care. © SD Biosensor Inc

Roche has announced to launch a SARS-CoV-2 point-of-care antigen test this month co-developed with SD Biosensor Inc. (South Korea).

Materials Innovation Factory at Unilever. © Unilever

Unilever has announced to invest €1bn globally to eliminate fossil fuels as a source of carbon in its cleaning products by 2030. 

AMR_Conference_Start-up_Winnter.png

15min to detect bacterial infections – that’s what British diagnostics company FluoretiQ Ltd is offering in the fight against antimicrobial resistance. A short interview with CEO Neciah Dorh.

AMR_Conference_sponsoren_neu_kl.jpg

With around 450 attendees, the five-day digital conference particularly focused on market conditions and financing. SMEs and global partners urged for more pull incentives.

A.baumannii. © CDC

Swiss BioVersys AG has secured a CHF19m Series B financing to push clinincal development of two antiinfectives against drug-resistant pathogens.

© NIH

PPF-owned company SOTIO has acquired the rights to use the BOXR CAR-T platform and products from Cambridge-based Unum Therapeutics.

Dividing Breast Cancer Cell. Credit: National Cancer Institute / Univ. of Pittsburgh Cancer Institute

Polyphor AG has licenced its metastatic cancer drug balixafortide to Fosun Pharma Co Ltd to market the drug exclusively in China.